High plasma fibrinogen level represents an independent negative prognostic factor regarding cancer-specific, metastasis-free, as well as overall survival in a European cohort of no...

por Pichler, M, Hutterer, G C, Stojakovic, T, Mannweiler, S, Pummer, K, Zigeuner, R
Publicado 2013

Validation of the pretreatment derived neutrophil–lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma

por Dalpiaz, O, Pichler, M, Mannweiler, S, Martín Hernández, J M, Stojakovic, T, Pummer, K, Zigeuner, R, Hutterer, G C
Publicado 2014

Validation of the pre-treatment neutrophil–lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients

por Pichler, M, Hutterer, G C, Stoeckigt, C, Chromecki, T F, Stojakovic, T, Golbeck, S, Eberhard, K, Gerger, A, Mannweiler, S, Pummer, K, Zigeuner, R
Publicado 2013

Serum sclerostin levels in renal cell carcinoma patients with bone metastases

por Wibmer, C., Amrein, K., Fahrleitner-Pammer, A., Gilg, M. M., Berghold, A., Hutterer, G. C., Maurer-Ertl, W., Gerger, A., Leithner, A., Pichler, M., Szkandera, J.
Publicado 2016

Long-term cardiovascular complications in stage I seminoma patients

por Terbuch, A., Posch, F., Annerer, L. M., Bauernhofer, T., Pichler, M., Szkandera, J., Hutterer, G. C., Pummer, K., Partl, R., Kapp, K. S., Stöger, H., Gerger, A., Stotz, M.
Publicado 2017